U.S. pharma giant copyright scrapped two experimental weight loss supplements past yr—a when-daily tablet, lotiglipron, due to elevated liver enzymes and also a two times-day by day pill, danuglipron, as a consequence of strong Unwanted effects—but CEO Albert Bourla has said the company is determined to “Engage in and acquire” during the be